Both have plenty to offer investors, but one has a better outlook.
They aren't just "pandemic stocks." ...
Shares of Reviva Pharmaceuticals Holdings, Inc. RVPH are tumbling after the company announced the pricing of its $10 million public offering of more than 6 million shares at $1.50 per share. Reviva ...
AbbVie Inc. (NYSE:ABBV) is one of Billionaire Ken Fisher’s 15 Most Notable Moves for 2026. AbbVie Inc. (NYSE:ABBV) is a constant part of the 13F portfolio of Fisher Asset Management since the start of ...
The recent news of Novo Nordisk’s nearly 10% stock decline – currently -6.6% – following disappointing Alzheimer’s trial results for its Ozempic pill highlights the volatility in pharmaceutical stocks ...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the Cheap Stocks to Buy for High Returns in 2026. On March 12, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) released positive data from ongoing ...
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the best biotech stocks to buy according to Wall Street analysts. On December 4, Citi analyst Yigal Nochomovitz reiterated a Buy rating on ...
After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional ...
Clinical-stage biotech Dianthus Therapeutics develops antibody therapies for severe autoimmune and neuromuscular conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results